Radiation for Oral Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to understand and treat oral premalignant and malignant tumors, which are early signs or actual cases of oral cancer. Researchers examine how these tumors behave and respond to treatments such as targeted therapy, immunotherapy, surgery, chemotherapy, and radiotherapy. They focus on using tissue samples and biomarkers—indicators in the body that can show disease presence or progress—to predict treatment effectiveness. Individuals diagnosed with conditions like leukoplakia, erythroplakia, or squamous cell carcinoma, or those who suspect they have these conditions, and are visiting UT MD Anderson Cancer Center for the first time or for follow-up, might be suitable for this trial. As a Phase 2 trial, this research measures treatment effectiveness in an initial, smaller group, offering participants a chance to contribute to the development of potentially effective therapies.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that radiation treatment is likely to be safe for humans?
Research has shown that radiation treatment for oral cancer can cause side effects because it affects both cancerous and healthy cells. Common side effects include mouth sores, dry mouth, and changes in taste. More serious issues, such as damage to the jawbone, can also occur. However, healthy cells typically heal after treatment. Although these side effects can be challenging, they are well-known, and doctors have methods to help manage them.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it aims to uncover the clinical and molecular features of oral premalignancy and oral cancer. Unlike traditional treatment methods that focus on removing cancerous tissue or using chemotherapy and radiation, this trial looks into the underlying biological changes that occur as oral tissues transition from normal to cancerous. This deeper understanding could lead to earlier detection and more targeted therapies in the future, potentially improving patient outcomes and reducing side effects associated with current treatments. By identifying specific molecular markers, researchers hope to pave the way for personalized treatment strategies that could revolutionize the management of oral cancer.
What evidence suggests that radiation might be an effective treatment for oral cancer?
Studies have shown that radiation therapy effectively treats oral cancer. One study found that intensity-modulated radiotherapy, a type of targeted radiation, helped 60% to 75% of patients live for at least five years after treatment. Another study found that combining radiation with chemotherapy extended patients' lives without cancer progression and improved overall survival. Starting radiation therapy promptly is crucial, as delays can worsen outcomes. These findings suggest that radiation plays a significant role in effectively managing oral cancer.46789
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo targeted therapy, immunotherapy, surgery, chemotherapy, and/or radiotherapy with serial assessments of tissue biopsy and biomarkers
Follow-up
Participants are monitored for safety, treatment response, and quality of life using MDASI-HN and MDADI questionnaires
What Are the Treatments Tested in This Trial?
Interventions
- Radiation
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Citations
Advances in radiotherapy for mouth neoplasms - PMC
Intensity-modulated radiotherapy, for example, has demonstrated 5-year overall survival rates ranging from 60 to 75%, with better local control ...
Outcomes of postoperative radiotherapy combined with or ...
The findings indicated that the combination of radiotherapy and chemotherapy resulted in significantly greater progression-free survival (PFS, p = 0.04) and OS ...
Oncologic Significance of Therapeutic Delays in Oral ...
Delays in initiating radiation therapy were associated with worse overall survival and disease-free survival. Meaning Efforts and resources ...
Post-operative radiotherapy for oral cavity squamous cell ...
Salvage radiotherapy in patients with early loco-regional recurrence, but no distant metastases, results in a 3 year recurrence-free rate of 36 % (95 % CI: 23– ...
5.
bmcoralhealth.biomedcentral.com
bmcoralhealth.biomedcentral.com/articles/10.1186/s12903-025-05877-8Impact of an oral care intervention protocol on oral health ...
Compared with routine care, oral care intervention improved oral health scores among cancer patients receiving head and neck radiation therapy/ ...
Oral Complications of Cancer Therapies - NCI
Some are helpful and some are harmful. Chemotherapy and radiation therapy may cause changes in the lining of the mouth and the salivary glands, ...
Oral management strategies for radiotherapy of head and ...
Radiotherapy-induced adverse events include oral mucositis, hyposalivation, loss of taste, dental caries, osteoradionecrosis, and trismus, all of which have an ...
Radiation
Although radiation damages both cancer cells and normal cells, normal, healthy cells are able to repair themselves and return to proper functioning.
Common oral complications of head and neck cancer ... - PMC
Patients undergoing radiation therapy for the head and neck are susceptible to a significant and often abrupt deterioration in their oral health.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.